Skip to main content
Clinical Trials/IRCT2017081535716N1
IRCT2017081535716N1
Completed
N/A

Changes of blood pressure and hemodynamic parameters after oral magnesium supplementation in patients with essential arterial hypertension

-0 sites48 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
-
Enrollment
48
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
-

Eligibility Criteria

Inclusion Criteria

  • age 24\-65; essential arterial hypertention; unchanged antihipertensive therapy for at least one month;
  • Exclusion criteria: renal diseases, gastrointestinal diseases, diabetes mellitus, diseases od adrenal, thyroid and parathyroid glands, angina pectoris, congestive heart failure, aortic coarctation, food and drugs allergy, pregnancy, lactation, myocardial infarction, coronary revascularisation, transitory ischemic attack, oral intake of magnesium supplements in the last one month

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials